Andrx lovastatin XL approved
Executive Summary
Andrx plans to launch extended-release Altocor (lovastatin) in the third quarter with a 280-rep sales force. The product was approved June 26. "At steady state in humans, the bioavailability of lovastatin, following the administration of Altocor, was 190% compared to lovastatin immediate-release," labeling states. The NDA for the cholesterol-lowering agent was filed March 29, 2001 (1"The Pink Sheet" April 2, 2001, p. 15)...